___________________________________________________________________________________
Table I . Baseline Characteristics. Historical information, clinical assessments and laboratory values are indicated at baseline for both benralizumab and placebo group. Total number of participant (n) is 24 with values expressed as mean. P values are calculated with unpaired two-tailed t-test unless otherwise indicated. ‡ symbol indicates a one-tailed Fisher’s exact test was performed. P value of 0.05 or less indicates significance by * symbol.